Correlation Between Tenaya Therapeutics and Vor Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tenaya Therapeutics and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenaya Therapeutics and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenaya Therapeutics and Vor Biopharma, you can compare the effects of market volatilities on Tenaya Therapeutics and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenaya Therapeutics with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenaya Therapeutics and Vor Biopharma.

Diversification Opportunities for Tenaya Therapeutics and Vor Biopharma

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tenaya and Vor is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Tenaya Therapeutics and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Tenaya Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenaya Therapeutics are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Tenaya Therapeutics i.e., Tenaya Therapeutics and Vor Biopharma go up and down completely randomly.

Pair Corralation between Tenaya Therapeutics and Vor Biopharma

Given the investment horizon of 90 days Tenaya Therapeutics is expected to under-perform the Vor Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Tenaya Therapeutics is 2.62 times less risky than Vor Biopharma. The stock trades about -0.38 of its potential returns per unit of risk. The Vor Biopharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  112.00  in Vor Biopharma on November 2, 2024 and sell it today you would earn a total of  27.00  from holding Vor Biopharma or generate 24.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tenaya Therapeutics  vs.  Vor Biopharma

 Performance 
       Timeline  
Tenaya Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tenaya Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Vor Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Tenaya Therapeutics and Vor Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tenaya Therapeutics and Vor Biopharma

The main advantage of trading using opposite Tenaya Therapeutics and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenaya Therapeutics position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.
The idea behind Tenaya Therapeutics and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets